tradingkey.logo

Ekso Bionics Holdings Inc

EKSO

4.310USD

-0.050-1.15%
Close 06/05, 16:00ETQuotes delayed by 15 min
121.53MMarket Cap
LossP/E TTM

Ekso Bionics Holdings Inc

4.310

-0.050-1.15%
More Details of Ekso Bionics Holdings Inc Company
Ekso Bionics Holdings, Inc. designs, develops, and markets exoskeleton products. Its exoskeleton technology serves people with physical disabilities or impairments in both physical rehabilitation and mobility. It operates as one segment with two markets: Enterprise Health and Personal Health. Its products include EksoNR, which is a wearable robotic exoskeleton designed for a rehabilitation setting; Ekso Indego Therapy is a modular, adjustable, lightweight, lower limb-powered exoskeleton; Ekso Indego Personal is a lower limb orthosis; Ekso Nomad is a power Knee Ankle Foot Orthosis, and Ekso EVO is a wearable upper body exoskeleton. It enables individuals with neurological conditions affecting gait, including acquired brain injury (ABI) and spinal cord injury (SCI), to rehabilitate, stand and walk again. Additionally, the devices assist people with a variety of upper extremity disabilities and enable industrial employees to perform challenging repetitive tasks for extended periods.
Company Info
Company codeEKSO
Company nameEkso Bionics Holdings Inc
IPO dateApr 10, 2013
Founded at2012
CEOMr. Scott G. Davis
Number of employees61
Security typeOrdinary Share
Fiscal year-endApr 10
Address101 Glacier Point
CitySAN RAFAEL
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code94901
Phone15109841761
Websitehttps://eksobionics.com/
Company codeEKSO
IPO dateApr 10, 2013
Founded at2012
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Steven A. Sherman
Mr. Steven A. Sherman
Executive Chairman of the Board
Executive Chairman of the Board
449.16K
+23.08%
Ms. Mary Ann Cloyd
Ms. Mary Ann Cloyd
Independent Director
Independent Director
25.23K
+166.00%
Ms. Deborah Lafer Scher
Ms. Deborah Lafer Scher
Independent Director
Independent Director
15.75K
--
Mr. Jason C. Jones
Mr. Jason C. Jones
Chief Operating Officer
Chief Operating Officer
14.90K
+54.55%
Mr. Jerome Wong
Mr. Jerome Wong
Chief Financial Officer, Corporate Secretary
Chief Financial Officer, Corporate Secretary
10.58K
+53.05%
Mr. David Carey
Mr. David Carey
Investor Relations
Investor Relations
--
--
Dr. Charles Li, Ph.D.
Dr. Charles Li, Ph.D.
Independent Director
Independent Director
--
--
Mr. Scott G. Davis
Mr. Scott G. Davis
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Dr. Corinna E. Lathan
Dr. Corinna E. Lathan
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Steven A. Sherman
Mr. Steven A. Sherman
Executive Chairman of the Board
Executive Chairman of the Board
449.16K
+23.08%
Ms. Mary Ann Cloyd
Ms. Mary Ann Cloyd
Independent Director
Independent Director
25.23K
+166.00%
Ms. Deborah Lafer Scher
Ms. Deborah Lafer Scher
Independent Director
Independent Director
15.75K
--
Mr. Jason C. Jones
Mr. Jason C. Jones
Chief Operating Officer
Chief Operating Officer
14.90K
+54.55%
Mr. Jerome Wong
Mr. Jerome Wong
Chief Financial Officer, Corporate Secretary
Chief Financial Officer, Corporate Secretary
10.58K
+53.05%
Mr. David Carey
Mr. David Carey
Investor Relations
Investor Relations
--
--
Revenue Breakdown
Currency: USDUpdate time: Sun, Apr 6
Currency: USDUpdate time: Sun, Apr 6
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
No Data
By RegionUSD
Name
Revenue
Proportion
United States
9.71M
54.18%
France
3.01M
16.77%
Other EMEA
2.94M
16.38%
APAC
1.85M
10.32%
Other Americas
421.00K
2.35%
By Business
By Region
No Data
Shareholder
Update time: Sat, May 17
Update time: Sat, May 17
Shareholder Statistics
Type
Shareholder Statistics
Shareholder
Proportion
Armistice Capital LLC
5.79%
The Vanguard Group, Inc.
1.68%
Li (Kecheng)
1.31%
Lathan (Corinna)
1.09%
Cloyd (Mary Ann)
1.07%
Other
89.06%
Shareholder Statistics
Shareholder
Proportion
Armistice Capital LLC
5.79%
The Vanguard Group, Inc.
1.68%
Li (Kecheng)
1.31%
Lathan (Corinna)
1.09%
Cloyd (Mary Ann)
1.07%
Other
89.06%
Type
Shareholder
Proportion
Hedge Fund
6.62%
Individual Investor
6.58%
Investment Advisor/Hedge Fund
3.62%
Investment Advisor
0.37%
Research Firm
0.07%
Family Office
0.04%
Other
82.69%
Institutional Shareholding
Update time: Sat, Feb 22
Update time: Sat, Feb 22
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q1
69
6.46M
24.09%
-487.19K
2024Q4
73
6.22M
25.06%
-1.22M
2024Q3
72
7.69M
35.95%
+2.06M
2024Q2
75
4.32M
22.05%
+86.91K
2024Q1
79
3.58M
21.92%
+291.20K
2023Q4
84
3.20M
21.39%
-96.00K
2023Q3
87
3.97M
27.62%
+342.40K
2023Q2
88
4.47M
31.89%
+476.23K
2023Q1
90
3.34M
25.52%
-152.01K
2022Q4
86
3.45M
26.50%
+117.22K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Armistice Capital LLC
1.73M
6.95%
-441.35K
-20.37%
Dec 31, 2024
The Vanguard Group, Inc.
594.43K
2.39%
--
--
Dec 31, 2024
Li (Kecheng)
224.74K
0.91%
+78.22K
+53.38%
Jun 06, 2024
Lathan (Corinna)
226.21K
0.91%
+78.22K
+52.85%
Jun 06, 2024
Cloyd (Mary Ann)
220.50K
0.89%
+78.22K
+54.97%
Jun 06, 2024
Davis (Scott Gerald)
228.40K
0.92%
+139.89K
+158.06%
Apr 10, 2024
Cresset Asset Management, LLC
300.00K
1.21%
-215.62K
-41.82%
Dec 31, 2024
Scher (Deborah Lafer)
78.22K
0.32%
+78.22K
--
Jun 06, 2024
Jones (Jason C)
144.65K
0.58%
-83.09K
-36.49%
Apr 10, 2024
Geode Capital Management, L.L.C.
163.94K
0.66%
-3.37K
-2.01%
Dec 31, 2024
View more
Related ETFs
Update time: Mon, Jun 2
Update time: Mon, Jun 2
Name
Proportion
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
Proportion0%
Dividend
A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Mar 24, 2020
Merger
15<1
Mar 24, 2020
Merger
15<1
Mar 24, 2020
Merger
15<1
Mar 24, 2020
Merger
15<1
Date
Type
Ratio
Mar 24, 2020
Merger
15<1
Mar 24, 2020
Merger
15<1
Mar 24, 2020
Merger
15<1
Mar 24, 2020
Merger
15<1
KeyAI